Sirnaomics' Grant - II Round

Sirnaomics raised a round of funding on June 25, 2012. Investors include National Institutes of Health.

Sirnaomics (圣诺制药) has developed a portfolio of intellectual properties in therapeutic areas of interest including anti-fibrotic medicine, cancer therapeutics, and others. STP705 is an anti-fib…

Articles about Sirnaomics' Grant - II Round: